Table 3.
Active Substances | Use Rate | Σ of Acute Toxicity Points | Σ of Chronic Toxicity Points | FPer | TRI | FPf | FCP | Points Allocated to HRI | CLP Classification |
---|---|---|---|---|---|---|---|---|---|
Profenofos | 12% | 20 | 18 | 1 | 1444 | 2 | 0.73 | 209.4 | H302, H312, H332 |
Indoxacarb | 6% | 15 | 18 | 1.5 | 1764 | 2 | 0.52 | 183.2 | H301, H317, H332, H372 |
Methomyl | 2% | 26 | 4 | 1.5 | 1024 | 2 | 0.78 | 160.0 | H300 |
Mancozeb | 1% | 10 | 6 | 1 | 256 | 2 | 2.00 | 102.4 | H317, H361d |
Cypermethrin | 13% | 18 | 4 | 2 | 676 | 2 | 0.53 | 71.3 | H302, H332, H335 |
Chlorothalonil | 1% | 20 | 0 | 1 | 400 | 1 | 1.63 | 65.0 | H317, H318, H330, H335, H351 |
Abamectin | 4% | 19 | 4 | 1.5 | 625 | 2 | 0.51 | 64.2 | H300, H330, H361d, H372 |
λ-Cyhalothrin | 35% | 25 | 0 | 2 | 625 | 2 | 0.50 | 64.0 | H301, H312, H330 |
Emamectin benzoate | 5% | 17 | 0 | 1 | 289 | 2 | 0.51 | 29.3 | Unclassified |
Acetamiprid | 26% | 9 | 2 | 1 | 121 | 2 | 0.52 | 12.5 | H302 |
Bacillus thuringiensis | 1% | Unclassified | Unclassified | Unclassified | Unclassified | Unclassified | Unclassified | Unclassified | Unclassified |
FPer = Factor taking into account the environmental persistence or the bioaccumulation potential in humans; TRI = Toxicological risk index of the active substance; FPf = Weighting factor related to formulation type; FCP = Compensation factor to account for the active substance concentration in the end-use product and the applied dose; HRI = Health risk index for the active substance; H300 = Fatal if swallowed; H301 = Toxic if swallowed; H302 = Harmful if swallowed; H312 = Harmful in contact with skin; H317 = May cause an allergic skin reaction; H318 = Causes serious eye damage; H330 = Fatal if inhaled; H332 = Harmful if inhaled; H335 = May cause respiratory irritation; H351 = Suspected of causing cancer; H361d = Suspected of damaging fertility or the unborn child; H372 = Causes damage to organs through prolonged or repeated exposure.